Importer of Controlled Substances Application: Lipomed
Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information
listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 24, 2023. Such persons may also file a written request for a hearing on the application on or before April 24, 2023.
ADDRESSES:
The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to
https://www.regulations.gov
and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on
https://www.regulations.gov.
If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on February 9, 2023 Lipomed, 150 Cambridepark Drive, Suite 705, Cambridge, Massachusetts 02140-2300, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration (FDA)
7365
II
Nabilone
7379
II
1-Phenylcyclohexylamine
7460
II
Phencyclidine
7471
II
ANPP (4-Anilino-N-phenethyl-4-piperidine)
8333
II
Phenylacetone
8501
II
1-Piperidinocyclohexanecarbonitrile
8603
II
Alphaprodine
9010
II
Anileridine
9020
II
Cocaine
9041
II
Codeine
9050
II
Etorphine HCl
9059
II
Dihydrocodeine
9120
II
Oxycodone
9143
II
Hydromorphone
9150
II
Diphenoxylate
9170
II
Ecgonine
9180
II
Ethylmorphine
9190
II
Hydrocodone
9193
II
Levomethorphan
9210
II
Levorphanol
9220
II
Isomethadone
9226
II
Meperidine
9230
II
Meperidine-intermediate-A
9232
II
Meperidine intermediate-B
9233
II
Meperidine intermediate-C
9234
II
Metazocine
9240
II
Methadone
9250
II
Methadone intermediate
9254
II
Metopon
9260
II
Dextropropoxyphene, bulk (non-dosage forms)
9273
II
Morphine
9300
II
Oripavine
9330
II
Thebaine
9333
II
Dihydroetorphine
9334
II
Levo-alphacetylmethadol
9648
II
Oxymorphone
9652
II
Noroxymorphone
9668
II
( printed page 17627)
Phenazocine
9715
II
Thiafentanil
9729
II
Piminodine
9730
II
Racemethorphan
9732
II
Racemorphan
9733
II
Alfentanil
9737
II
Remifentanil
9739
II
Sufentanil
9740
II
Carfentanil
9743
II
Tapentadol
9780
II
Bezitramide
9800
II
Fentanyl
9801
II
Moramide-intermediate
9802
II
The company plans to import analytical reference standards for distribution to its customers for research and analytics purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized in 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.